Liu X, Li S, Wei X, Zhao Y, Lai D, Zhou L, Wang M. Total synthesis of Palmarumycin BGs, C
1 and Guignardin E.
RSC Adv 2020;
10:1588-1594. [PMID:
35494718 PMCID:
PMC9047396 DOI:
10.1039/c9ra10316c]
[Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2019] [Accepted: 12/19/2019] [Indexed: 11/21/2022] Open
Abstract
The first total synthesis of Palmarumycin BG1–3, BG5–6, C1 and Guignardin E (1–7) were achieved by the same intermediate Palmarumycin C2 through a N-benzyl cinchoninium chloride-catalyzed epoxidation, an organoselenium-mediated reduction, and a cerium(iii) chloride hydrate-promoted regioselective ring-opening and elimination of cyclic α,β-epoxy ketone as the key steps via6–7 step routes using 1,8-dihydroxynaphthalene (DHN) and 5-methoxytetralone as the starting materials in overall yields of 1.0–17.4%, respectively. Their structures and absolute configurations were characterized and determined by 1H, 13C NMR, IR, HR-ESI-MS and X-ray diffraction data. These compounds displayed significant inhibition activities against HCT116, U87-MG, HepG2, BGC823 and PC9 cell lines.
The first total syntheses of Palmarumycin BG1–3, BG5–6, C1 and Guignardin E were achieved. These compounds displayed significant inhibition activities against HCT116, U87-MG, HepG2, BGC823 and PC9 cell lines.![]()
Collapse